Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03797495 · ClinicalTrials.gov registry record
Study of Individuals Affected With Hypoplasminogenemia
A clinical trial of Plasminogen Deficiency, sponsored by Indiana Hemophilia &Thrombosis Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 20
- Study locations
NCT03797495: Recruiting study of Plasminogen Deficiency, sponsored by Indiana Hemophilia &Thrombosis Center.
NCT03797495 is a study of Plasminogen Deficiency that is actively recruiting participants, run by Indiana Hemophilia &Thrombosis Center. The registered enrollment target is 100 participants. The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03797495, a study of Plasminogen Deficiency, is actively recruiting participants, sponsored by Indiana Hemophilia &Thrombosis Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is an Investigator initiated retrospective and prospective single cohort study. The study will utilize an international registry and develop a specimen biobank to provide an improved understanding of the natural history of hyposplasminogenemia, to elucidate the heterogeneity of phenotypic expression, identify markers to predict disease course, and inform improved therapeutic modalities
Primary Outcome
1. Recruit 100 subjects with hypoplasminogenemia and their first-degree family members 2. Collect up to 1 year retrospective and 3 year prospective data on symptoms, treatment and interventions
Conditions Studied
Study Locations (20)
Other
- Hospital Britanico Buenos Aires - Buenos Aires
- Children's Health Queensland Hospital and Health Service - South Brisbane
- Medical University of Innsbruck, University Clinic for Pediatrics and Adolescent Medicine - Innsbruck
- University of Saskatchewan - Saskatoon
New York
- Stony Brook University | Stony Brook Medicine - East Setauket
- SUNY Upstate Medical University, Pediatric Hematology/Oncology - Syracuse
Texas
- Cook Children's Medical Center - Forth Worth
- The University of Texas Health Science Center at Houston - Houston
Quebec
- CHU Sainte-Justine - Montreal
- CHU de Québec Université Laval - Québec
Alabama
- The University of Alabama (UAB) - Birmingham
Illinois
- Rush University Medical Center - Chicago
Indiana
- Indiana Hemophila @Thrombosis Center - Indianapolis
Minnesota
- University of Minnesota, Pediatric Hem/Onc & Cancer Survivorship Program - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2027-04-19 |
What NCT03797495 shows while recruiting
NCT03797495 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Plasminogen Deficiency appearing as the primary indexed condition, and to 0 interventions.
NCT03797495 names 20 study sites across 14 states, led by Other, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT03797495 about?
NCT03797495 is a clinical study titled "Study of Individuals Affected With Hypoplasminogenemia". This is an Investigator initiated retrospective and prospective single cohort study. The study will utilize an international registry and develop a specimen biobank to provide an improved understanding of the natural history of hyposplasminogenemia, to elucidate the heterogeneity of phenotypic expre...
What is the current status of trial NCT03797495?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2018-12-18. Estimated completion is 2027-04-19.
What conditions does trial NCT03797495 study?
This clinical trial studies the following conditions: Plasminogen Deficiency.
Who is sponsoring clinical trial NCT03797495?
This trial is sponsored by Indiana Hemophilia &Thrombosis Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03797495 being conducted?
This trial has 20 study locations across Alabama, Illinois, Indiana, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI